These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11584262)

  • 1. The role of economic evaluation in infection control.
    Saint S; Chenoweth C; Fendrick AM
    Am J Infect Control; 2001 Oct; 29(5):338-44. PubMed ID: 11584262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic evaluation in health: applications in infectious diseases].
    Vanni T; Luz PM; Ribeiro RA; Novaes HM; Polanczyk CA
    Cad Saude Publica; 2009 Dec; 25(12):2543-52. PubMed ID: 20191146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation: what does a nurse manager need to know?
    Douglas HR; Normand C
    J Nurs Manag; 2005 Sep; 13(5):419-27. PubMed ID: 16108780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economic studies: an introduction to cost-benefit, cost-effectiveness, and cost-utility analyses.
    Angevine PD; Berven S
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S9-15. PubMed ID: 25299265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluations and their use in infection prevention and control: a narrative review.
    Rennert-May E; Conly J; Leal J; Smith S; Manns B
    Antimicrob Resist Infect Control; 2018; 7():31. PubMed ID: 29492261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation alongside cancer trials: methodological and practical aspects.
    Bonsel GJ; Rutten FF; Uyl-de Groot CA
    Eur J Cancer; 1993; 29A Suppl 7():S10-4. PubMed ID: 8312059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of decision analytic modeling in the health economic assessment of spinal intervention.
    Edwards NC; Skelly AC; Ziewacz JE; Cahill K; McGirt MJ
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S16-42. PubMed ID: 25299257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic endpoints in clinical trials.
    Cook J; Drummond M; Heyse JF
    Stat Methods Med Res; 2004 Apr; 13(2):157-76. PubMed ID: 15068259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions.
    Miyamoto GC; Ben ÂJ; Bosmans JE; van Tulder MW; Lin CC; Cabral CMN; van Dongen JM
    Braz J Phys Ther; 2021; 25(5):514-529. PubMed ID: 34340933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value for money in the health sector: the contribution of primary health care.
    Mills A; Drummond M
    Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic evaluation: important principles and methodology.
    Rudmik L; Drummond M
    Laryngoscope; 2013 Jun; 123(6):1341-7. PubMed ID: 23483522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and benefits in hospital infection control].
    Kumasaka K; Yanai M
    Nihon Rinsho; 2002 Nov; 60(11):2230-5. PubMed ID: 12440135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Based Decision Making 7: Health Economics in Clinical Research.
    Manns BJ
    Methods Mol Biol; 2021; 2249():501-516. PubMed ID: 33871861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.